Professor of Immunology and Immunogenetics
Department Pathobiology
University of Guelph
CEO ImmunoCeutica Inc
Guelph, Ontario
Canada
Website: https://immunoceutica.ca
Research Gate: https://www.researchgate.net/profile/Bonnie-Mallard
Twitter X: https://x.com/immunoceutica
Facebook: https://www.facebook.com/profile.php?id=100089298662285
Instagram: https://www.instagram.com/immunoceutica/
LinkedIn: https://www.linkedin.com/in/bonnie-mallard-0b417721/?originalSubdomain=ca
LinkedIn: https://www.linkedin.com/company/immunoceutica/
ABOUT DR. MALLARD
Dr. Mallard’s research program focuses on genetic regulation of the immune system in mammals and its impact on disease resistance. She is also interested in the impact of immunoceuticals on the immune system, including the role of Vitamin D.
Areas of expertise: Dr. Mallard’s research focuses mainly on preventative approaches to improve health that are sustainable for the environment, and that enhance both human and animal well-being. Preventive approaches to health include both genetic and environmental strategies. Genetic strategies include identification of genes that regulate immunity; whereas, environmental strategies would include immuno-modulatory nutrients and customized health management.
She has worked with numerous species over three decades and is well positioned to speak about infectious diseases, including zoonotic diseases passed between animals and humans that are responsible for the majority of epidemics and pandemics. She has taught immunology for 30 years at the undergraduate and most advanced graduate levels. Dr. Mallard also has an ever growing interest on the impact of nutrients on immune function.
Dr. Mallard’s primary academic activities include:
Research:
- Immunogenetics: Genetic/genomic/epigenetic regulation of immune response and immunity to infectious diseases. Research with many species, including but not limited to mice, rabbits, poultry, horses, swine and cattle. This is particularly pertinent since epidemics and pandemics generally arise from animal reservoirs.
- Dr. Mallard has been recognized national and internationally for her work on the High Immune Response Technology (HIR™) for improving animal health and food safety. This non-GMO technology is successfully marketed under the Immunity+ trademark. This is a patented method that identifies individuals with the highest level of immuno-competency, thereby reducing disease occurrence, improving food safety and promoting animal well-being. This product is sold in over 80 countries worldwide.
- Dr. Mallard holds several patents relating to the field of immunology, several related to immuno-genetics and one for a vaccine against pleuropneumonia.
- Xenotransplantation is another area of expertise for Dr. Mallard. She has a longstanding interest in induction of immunological tolerance and the role of major histocompatibility antigens.
- Currently Professor Mallard manages a modern immunology lab which includes graduate students, post-doctoral fellows, research associates, research technicians and a variety of undergraduate students.
- Dr. Mallard has held over $50M in research funding over the course of her career.
Teaching:
Professor Mallard is an experienced teacher with good teaching ratings. At the University of Guelph, she has been the co-coordinator of an undergraduate Immunology course for several decades which generally enrolls over 400 students each year, many of which go on to be health care practitioners. She also has coordinated the graduate immunology course, “Advanced Topics in Immunology” in the Department of Pathobiology for over 20 years. Additionally, she gives lectures at ImmunoCeutica Inc to health care professionals and health conscious individuals (https://immunoceutica.ca/about-us/).
Boards and Panels:
Dr. Mallard has been involved with a number of organizations including sitting on the editorial board for Animal Biotechnology for the last 15 years, participating on various Scientific Advisory Boards, offering her expertise to a European Expert Panel on Disease Control and participating on a Mastitis Expert Panel in Holland; as well as an international panel of experts reporting to Meat Livestock Australia, to name just a few.
AWARDS & ACCOLADES
Dr. Mallard is the winner of numerous awards, including the prestigious Governor General’s Award for Innovation and the NSERC Synergy Prize for her work in immunogenetics. She is also the CEO of ImmunoCeutica Labs and Technologies which seeks to help empower immunity naturally.
As an immunologist it seems clear to me that to optimize immune function it is critically important to test vitamin D levels and then adjust supplementation accordingly. Test, don’t guess.
Dr. Mallard is also the recipient of the Pzifer Award for Research Excellence, the World Dairy Expo Innovation Award for Immunity+/High Immune Response (HIR™) Technology, the Zoetis Research Award for work in immunogenetics and the University of Guelph 30 Years of Service recognition. In 2017, Professor Mallard won the prestigious Canada’s Governor General’s Award for Innovation in recognition of the High Immune Response technology. In 2018, she received the University of Guelph Innovation of the Year Award, the YMCA Women of Distinction Award and the Lifetime Achievement Award. In 2018, along with the Semex Alliance they won the best new product award for the genomics test for HIR, called Immunity female in the Elevate platform, as well as the Summit Award in 2019 for the Crushing Disease campaign with Immunity+. Dr Mallard was the 2020-21 winner of the prestigious NSERC Synergy Prize making her the first Canadian to have won both the Governor General’s Award and the NSERC Synergy Prize for innovations in the area of immunogenetics.
TOP PUBLICATIONS
Dr. Mallard has published extensively with over 100 full length publications in referred journals, and has presented hundreds of abstracts and oral presentations at scientific meetings. She has also published several book chapters on genetic regulation of the immune system.
Vitamin D and other Immunoceutical Publications:
https://www.mdpi.com/2072-6643/14/19/4075
https://journal.lib.uoguelph.ca/index.php/surg/article/view/7081
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604897/
https://journal.lib.uoguelph.ca/index.php/surg/article/view/7081
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1263787/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1263820/